Penn Heart & Vascular interventionalist Howard Herrmann, MD, and cardiac surgeon Joseph Bavaria, MD, offer the insight of principal investigators as they discuss transcatheter aortic valve replacement (TAVR) therapy.
Genetic Risk Information for Coronary Heart Disease Leads to Lower Bad Cholesterol
Percutaneous Ventricular Assist Device and Extracorporeal Life Support (ECMO)
TAVR for Aortic Stenosis: Case Report
Assessing the Patient for Aortic Valve Disease
Assessing the Patient for Mitral Valve Disease
Assessing the Patient for Mitral and Aortic Valve Surgery: An Introduction